Invesco’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $985K | Buy |
105,157
+28,309
| +37% | +$265K | ﹤0.01% | 2846 |
|
|
2025
Q1 | $944K | Buy |
76,848
+25,524
| +50% | +$314K | ﹤0.01% | 2849 |
|
|
2024
Q4 | $679K | Buy |
51,324
+684
| +1% | +$9.04K | ﹤0.01% | 3085 |
|
|
2024
Q3 | $975K | Buy |
50,640
+579
| +1% | +$11.1K | ﹤0.01% | 2906 |
|
|
2024
Q2 | $1.03M | Buy |
50,061
+1,226
| +3% | +$25.2K | ﹤0.01% | 2905 |
|
|
2024
Q1 | $1.16M | Buy |
48,835
+19,515
| +67% | +$464K | ﹤0.01% | 2915 |
|
|
2023
Q4 | $634K | Sell |
29,320
-7,223
| -20% | -$156K | ﹤0.01% | 3088 |
|
|
2023
Q3 | $531K | Buy |
36,543
+6,095
| +20% | +$88.5K | ﹤0.01% | 3158 |
|
|
2023
Q2 | $637K | Sell |
30,448
-179,705
| -86% | -$3.76M | ﹤0.01% | 3112 |
|
|
2023
Q1 | $4.44M | Buy |
210,153
+190,006
| +943% | +$4.01M | ﹤0.01% | 2271 |
|
|
2022
Q4 | $513K | Sell |
20,147
-56,244
| -74% | -$1.43M | ﹤0.01% | 3232 |
|
|
2022
Q3 | $1.84M | Buy |
76,391
+53,856
| +239% | +$1.29M | ﹤0.01% | 2662 |
|
|
2022
Q2 | $434K | Buy |
22,535
+4,779
| +27% | +$92K | ﹤0.01% | 3374 |
|
|
2022
Q1 | $308K | Buy |
17,756
+148
| +0.8% | +$2.57K | ﹤0.01% | 3591 |
|
|
2021
Q4 | $386K | Sell |
17,608
-2,385
| -12% | -$52.3K | ﹤0.01% | 3464 |
|
|
2021
Q3 | $383K | Buy |
19,993
+2,276
| +13% | +$43.6K | ﹤0.01% | 3515 |
|
|
2021
Q2 | $305K | Buy |
17,717
+8,069
| +84% | +$139K | ﹤0.01% | 3598 |
|
|
2021
Q1 | $216K | Sell |
9,648
-302,815
| -97% | -$6.78M | ﹤0.01% | 3642 |
|
|
2020
Q4 | $6.95M | Buy |
312,463
+247,025
| +377% | +$5.49M | ﹤0.01% | 2003 |
|
|
2020
Q3 | $966K | Buy |
+65,438
| New | +$966K | ﹤0.01% | 2826 |
|
|
2020
Q2 | – | Sell |
-60,152
| Closed | -$660K | – | 3639 |
|
|
2020
Q1 | $660K | Buy |
+60,152
| New | +$660K | ﹤0.01% | 2924 |
|